BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17445240)

  • 1. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.
    Haller J; Mátyás F; Soproni K; Varga B; Barsy B; Németh B; Mikics E; Freund TF; Hájos N
    Eur J Neurosci; 2007 Apr; 25(8):2445-56. PubMed ID: 17445240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
    Hájos N; Freund TF
    Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
    Hoffman AF; Lupica CR
    J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
    Szabo B; Siemes S; Wallmichrath I
    Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
    Hájos N; Katona I; Naiem SS; MacKie K; Ledent C; Mody I; Freund TF
    Eur J Neurosci; 2000 Sep; 12(9):3239-49. PubMed ID: 10998107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
    Haller J; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB
    Kirson D; Oleata CS; Parsons LH; Ciccocioppo R; Roberto M
    Addict Biol; 2018 Mar; 23(2):676-688. PubMed ID: 28656627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.
    Li ZW; Zhang J; Ouyang CH; Li CY; Zhao FB; Liu YW; Ai YX; Hu WP
    Br J Pharmacol; 2009 Dec; 158(8):1904-10. PubMed ID: 19917064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
    Németh B; Ledent C; Freund TF; Hájos N
    Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse.
    Azad SC; Eder M; Marsicano G; Lutz B; Zieglgänsberger W; Rammes G
    Learn Mem; 2003; 10(2):116-28. PubMed ID: 12663750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata.
    Wallmichrath I; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
    Hoffman AF; Macgill AM; Smith D; Oz M; Lupica CR
    Eur J Neurosci; 2005 Nov; 22(9):2387-91. PubMed ID: 16262678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-induced hyperphagia: correlation with inhibition of proopiomelanocortin neurons?
    Ho J; Cox JM; Wagner EJ
    Physiol Behav; 2007 Oct; 92(3):507-19. PubMed ID: 17532014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex.
    Cass DK; Flores-Barrera E; Thomases DR; Vital WF; Caballero A; Tseng KY
    Mol Psychiatry; 2014 May; 19(5):536-43. PubMed ID: 24589887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.